当前位置:
X-MOL 学术
›
Nat. Biotechnol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Amgen cholesterol antibody feud could kill key IP rule
Nature Biotechnology ( IF 46.9 ) Pub Date : 2017-12-08 , DOI: 10.1038/nbt1217-1118 Mark Ratner
Nature Biotechnology ( IF 46.9 ) Pub Date : 2017-12-08 , DOI: 10.1038/nbt1217-1118 Mark Ratner
Amgen cholesterol antibody feud could kill key IP rule
中文翻译:
安进胆固醇抗体之争可能会杀死关键的IP规则
安进胆固醇抗体之争可能会杀死关键的IP规则
更新日期:2017-12-10
Amgen cholesterol antibody feud could kill key IP rule, Published online: 08 December 2017; doi:10.1038/nbt1217-1118
Amgen cholesterol antibody feud could kill key IP rule中文翻译:
安进胆固醇抗体之争可能会杀死关键的IP规则
安进胆固醇抗体之争可能会杀死关键的IP规则
Amgen胆固醇抗体之争可能会杀死关键的IP规则,在线发布:2017年12月8日;doi:10.1038 / nbt1217-1118
安进胆固醇抗体之争可能会杀死关键的IP规则